Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO2 pseudogene 11 (MTCO2P11) is a nuclear pseudogene related to the mitochondrially encoded cytochrome c oxidase II (MT-CO2, also known as COX2, Cytochrome c oxidase subunit II)[2][4][7]. Unlike the functional MT-CO2 gene, which encodes a key subunit of Complex IV in the mitochondrial respiratory chain and is essential for cellular energy production[1][6], MTCO2P11 does not encode a functional protein and is typically considered non-coding "junk DNA"[2][4]. MTCO2P11 is located on chromosome 9 (hg38: chr9:5098341-5099325)[4]. There is no evidence to support its role as a therapeutic target, and there are no known biological functions, disease associations, or known interactions with drugs. The designation as a pseudogene implies MTCO2P11 is generally not transcribed or translated and does not participate in enzymatic, receptor, transporter, or signaling activities relevant to molecular pharmacology[2][7][9]. Pseudogenes are typically remnants of gene duplication or retrotransposition events that have lost their protein-coding capacity and regulatory elements but can sometimes exert regulatory effects via non-coding RNA or act as microRNA decoys[9]. However, for MTCO2P11, no such functions are recognized in the current literature or major genomic databases[2][4][7]. The MT-CO2 gene (not MTCO2P11) codes for a critical mitochondrial enzyme subunit, but the pseudogene variant is not involved in any known biological pathways or disease processes, nor does it serve as a biomarker or safety concern in clinical or pharmacological contexts[1][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CO2 pseudogene 11 (MTCO2P11).